PER1 and endometrial carcinoma: Yeh KT et al [14], [28] reported that the mechanism of decreased PER1 expression in endometrial carcinoma and breast cancer tissues was that cytosine-phosphate guanosine (CpG) sites promoter methylation of the PER1 gene and this lead to downregulation and inhibition of PER1 expression.